CD4 and tuberculosis: A randomized trial carried out in Haiti demonstrates that starting ART immediately in patients enrolled with less than 350 CD4/mm3 decreases the rates of death and incident tuberculosis compared to starting ART at 200 CD4/mm3 [15].